155 related articles for article (PubMed ID: 29752427)
1. Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R.
Haspula D; Clark MA
J Pharmacol Exp Ther; 2018 Aug; 366(2):251-264. PubMed ID: 29752427
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.
O'Connor AT; Clark MA
Neurochem Res; 2018 Jul; 43(7):1297-1307. PubMed ID: 29858771
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease.
Chow BS; Allen TJ
Clin Sci (Lond); 2016 Aug; 130(15):1307-26. PubMed ID: 27358027
[TBL] [Abstract][Full Text] [Related]
4. Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases.
Huber G; Schuster F; Raasch W
Pharmacol Res; 2017 Nov; 125(Pt A):72-90. PubMed ID: 28687340
[TBL] [Abstract][Full Text] [Related]
5. RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders.
Rocha NP; Simoes E Silva AC; Prestes TRR; Feracin V; Machado CA; Ferreira RN; Teixeira AL; de Miranda AS
Curr Med Chem; 2018; 25(28):3333-3352. PubMed ID: 29484978
[TBL] [Abstract][Full Text] [Related]
6. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.
Lazartigues E; Feng Y; Lavoie JL
Curr Pharm Des; 2007; 13(12):1231-45. PubMed ID: 17504232
[TBL] [Abstract][Full Text] [Related]
7. New and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): Focus on cardiovascular and neurological diseases.
Mascolo A; Sessa M; Scavone C; De Angelis A; Vitale C; Berrino L; Rossi F; Rosano G; Capuano A
Int J Cardiol; 2017 Jan; 227():734-742. PubMed ID: 27823897
[TBL] [Abstract][Full Text] [Related]
8. Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.
Zhang JY; Yin Y; Ni L; Long Q; You L; Zhang Q; Lin SY; Chen J
Br J Nutr; 2016 Nov; 116(9):1491-1501. PubMed ID: 27753426
[TBL] [Abstract][Full Text] [Related]
9. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
10. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
Borghi C; ; Rossi F;
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
[TBL] [Abstract][Full Text] [Related]
11. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects.
Vinturache AE; Smith FG
Vascul Pharmacol; 2014 Dec; 63(3):145-54. PubMed ID: 25451565
[TBL] [Abstract][Full Text] [Related]
13. Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.
Paulis L; Foulquier S; Namsolleck P; Recarti C; Steckelings UM; Unger T
Drugs; 2016 Jan; 76(1):1-12. PubMed ID: 26631237
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies.
Torika N; Asraf K; Danon A; Apte RN; Fleisher-Berkovich S
PLoS One; 2016; 11(5):e0155823. PubMed ID: 27187688
[TBL] [Abstract][Full Text] [Related]
15. Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures.
Dominguez-Meijide A; Rodriguez-Perez AI; Diaz-Ruiz C; Guerra MJ; Labandeira-Garcia JL
Brain Behav Immun; 2017 May; 62():277-290. PubMed ID: 28232171
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells.
Garrido-Gil P; Rodriguez-Perez AI; Fernandez-Rodriguez P; Lanciego JL; Labandeira-Garcia JL
Brain Struct Funct; 2017 Aug; 222(6):2559-2571. PubMed ID: 28161727
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of Angiotensin II receptor blockers in brain disorders.
Saavedra JM
Pharmacol Res; 2017 Nov; 125(Pt A):91-103. PubMed ID: 28711402
[TBL] [Abstract][Full Text] [Related]
18. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
19. The CNS renin-angiotensin system.
von Bohlen und Halbach O; Albrecht D
Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
[TBL] [Abstract][Full Text] [Related]
20. Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia.
Cosarderelioglu C; Nidadavolu LS; George CJ; Marx-Rattner R; Powell L; Xue QL; Tian J; Salib J; Oh ES; Ferrucci L; Dincer P; Bennett DA; Walston JD; Abadir PM
J Gerontol A Biol Sci Med Sci; 2022 Apr; 77(4):664-672. PubMed ID: 34914835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
